Editing Firm involving high tech, life sciences and biotech

Austrianova is one business that does services that involves high tech, life sciences and biotech. It is combined with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science associated company that concentrate in the insertion of living cells or bacteria in little casings for protection which is also acknowledged as cell encapsulation technology, isolation, storage and transportation. We were first built in the year 2007 and was based in Singapore's best study biotech hub, Biopolis that has global dream in providing encapsulation services like micro encapsulation. 

There is a quick advancing area of attention in healthy repair and more specifically, in the subject of neutraceuticals which is the comprehension and use of probiotic bacteria. So, probiotics encapsulation was formed. The cell-in-a-box technology was formed by Austranova with the vision to guard, isolate, collect and move living cells. This protective technology can be used for several purposes and can be applied to probiotics, cosmetics and agriculture environmental protection and monitoring as well as forming the foundation of a influential exploration device. 

In healthcare, this technology helps facilitates secure implantation of cells or stem cells such as cell therapy, holding them separated from the immune system and enabling long time manufacturing of therapeutic molecules in patients. In biotechnology, the cell-in-a-box procedure defends cells in bioreactors and fermentors and at the same time, it simplifies sanitization of bioproducts created from the cells and it lessen production cost too.

A wide ruler cGMP facility for the production of biomedical grade encapsulated cell products was beforehand fruitfully established and right now, Austrianova is in the procedure of developing this capability in the whole of SE Asia. This means the use of cell-in-a-box was quite a accomplishment for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to enable minor doses of chemotherapy to be used more efficaciously without the common incapacitating side outcomes. The encapsulated cell are placed, using supraselective catheterisation, into blood vessels that drives to the tumor where they locally switch a chemotherapeutic product to its tumor toxic product. 

Come to our website for more details: <strong><b>[http://austrianova.com/ Capsules]</b></strong>, <strong><b>[http://austrianova.com/ Stem Cells]</b></strong>, <strong><b>[http://austrianova.com/ Encapsulation Technology]</b></strong>.